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concepción Violán1,2*, Sergio Fernández‑Bertolín1,2, Marina Guisado‑Clavero1,2, 
Quintí Foguet‑Boreu 1,2,3, Jose M. Valderas4, Josep Vidal Manzano5, 
Albert Roso‑Llorach1,2,6 & Margarita Cabrera‑Bean 5,6
this study aimed to analyse the trajectories and mortality of multimorbidity patterns in patients aged 
65 to 99 years in Catalonia (Spain). Five year (2012–2016) data of 916,619 participants from a primary 
care, population‑based electronic health record database (Information System for Research in Primary 
Care, SIDIAP) were included in this retrospective cohort study. Individual longitudinal trajectories 
were modelled with a Hidden Markov Model across multimorbidity patterns. We computed the 
mortality hazard using Cox regression models to estimate survival in multimorbidity patterns. Ten 
multimorbidity patterns were originally identified and two more states (death and drop‑outs) were 
subsequently added. At baseline, the most frequent cluster was the Non-Specific Pattern (42%), and 
the least frequent the Multisystem Pattern (1.6%). Most participants stayed in the same cluster over 
the 5 year follow‑up period, from 92.1% in the Nervous, Musculoskeletal pattern to 59.2% in the 
Cardio-Circulatory and Renal pattern. The highest mortality rates were observed for patterns that 
included cardio‑circulatory diseases: Cardio-Circulatory and Renal (37.1%); Nervous, Digestive and 
Circulatory (31.8%); and Cardio-Circulatory, Mental, Respiratory and Genitourinary (28.8%). This study 
demonstrates the feasibility of characterizing multimorbidity patterns along time. Multimorbidity 
trajectories were generally stable, although changes in specific multimorbidity patterns were 
observed. The Hidden Markov Model is useful for modelling transitions across multimorbidity patterns 
and mortality risk. Our findings suggest that health interventions targeting specific multimorbidity 
patterns may reduce mortality in patients with multimorbidity.
Multimorbidity, the coexistence of two or more chronic diseases in the same individual, is a growing global 
 concern1. The estimated prevalence of multimorbidity in people over 65 years of age reaches 95% in some  studies2. 
Population ageing means that multimorbidity rates will dramatically rise in the coming  decades3. The WHO 
World Report on Ageing and Health advocates for the characterization of health trajectories to better understand 
the dynamics of ageing and to optimize well-being and health gains from  interventions4. This implies measure-
ments of multimorbidity more sophisticated than the usual analyses limited to weighted counts of conditions 
for estimating the prevalence and incidence of  multimorbidity5.
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The longitudinal characterization of disease patterns is essential for uncovering relationships over time and 
for the development of prediction  models6. To date, studies have predominantly focused on diseases rather than 
persons, since the unit of analysis is the identification of multimorbidity  patterns7–9.. This approach precludes 
the exploration of the trajectories and evolution of multimorbidity over a persons’  lifetime7. By refocusing the 
analysis on individuals, we can obtain a better characterisation of the population groups with multimorbidity. 
In turn, we will produce more accurate data for the development of clinical guidelines, and for more targeted 
preventive, diagnostic, prognostic and treatment  strategies10,11 .
Most longitudinal analyses have used a cross-sectional design and studies that include the whole longitudinal 
structure of the data are  scarce12–14. To define the trajectories of multimorbidity patterns, it is essential to consider 
the different diseases that affect people over time. Therefore, it is necessary to conduct studies that offer more 
information on how individual techniques are influenced by specific identification of disease patterns or even 
test new statistical approaches adapted for the study of multimorbidity.
In recent years, dynamic machine learning methodologies like the Hidden Markov Models (HMM) have 
been applied to identify multimorbidity patterns. The HMM integrate a dynamic Bayesian network that works 
with the temporal sequence of the observed patient’s data. In a HMM, the observations are random variables 
conditioned by a hidden state or cluster. For instance, if it is considered that each patient belongs to one multi-
morbidity pattern each year; it is not possible to observe the cluster directly. Instead, we have the data contained 
in the Electronic Health Records (EHR) for each year of study, which are the observed outcomes from the time 
series. Previous studies have applied dynamic Bayesian networks for health analysis. For instance, a Dutch 
analysis applied HMM to a large dataset from practices of patients that had events on comorbidities related to 
atherosclerosis and the discovered hidden clusters were further correlated to medical-oriented  outcomes15. Other 
examples relate to the decomposition of shared latent factors using Bayesian multimorbidity dependency maps 
and to healthcare predictive risk  modelling16,17. Primary Care EHR, where data are routinely collected, represents 
a unique resource for the longitudinal analysis of multimorbidity patterns.
The aim of this study is to analyse and describe multimorbidity patterns, their trajectories and mortality over 
time in people over 65 years of age during the 2012–2016 period in Catalonia using primary care EHR.
Methods
Design, setting, and study population. A longitudinal study was conducted in Catalonia (Spain), a 
Mediterranean region of 7,515,398  inhabitants18. The Spanish National Health Service provides universal cov-
erage, financed mainly by tax revenue. The Catalan Health Institute (CHI) manages 284 primary health care 
centres (PHCs) that serve 5,501,784 patients (274 PHCs), which represent 74% of the population; the remaining 
PHCs are managed by other providers. A total of 916,619 people were included at baseline and 743,827 com-
pleted all follow-up (see Fig. 1).
Inclusion criteria consisted of individuals aged 65–99 years on 31 December 2011 that survived until 31 
December 2012 (index date), which had consulted their primary care physician at least once during the 5-year 
study period (2012–2016). No new entries were allowed in the cohort. Attrition was caused by mortality or 
dropouts due to transfer to other health systems.
Data sources. The CHI’s Information System for Research in Primary Care (SIDIAP) contains the clinical 
information as EHR recorded by the PHCs since  200619. The SIDIAP database includes anonymized longitudinal 
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Figure 1.  Longitudinal Flow Chart of study period (year 2012–2016; N = 916,619 persons).
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EHR from primary and secondary care that collect information on demographics, symptoms, diagnoses, pre-
scriptions and socio-economic status.
Variables. All variables were obtained directly from the SIDIAP database.
Chronic diseases. Diseases are coded in the SIDIAP using the International Classification of Diseases version 
10 (ICD-10). An operational definition of multimorbidity was used based on the selected 60 chronic diseases 
determined by the Swedish National study of Aging and Care in Kungsholmen (SNAC-K), with additional clini-
cal, lab and drug related parameters for the assessment of certain conditions. Multimorbidity was defined by the 
presence of two or more diagnoses from the 60 chronic disease categories defined in the SNAC-K  study20 (see 
Supplementary 1).
Death and drop out. Death was measured as the occurrence of this event, regardless of cause. The start date for 
calculation of risk of death was 1 January 2013. A person that dropped out of the health system during the study 
period was considered lost to follow-up (drop-out).
Other variables. Additional variables included in the study (baseline and end of study) were socio-demo-
graphic variables such as age at baseline (years), sex (men, women), socio-economic status (MEDEA index; 
quintiles from least to most deprived)21, number of invoiced drugs and polypharmacy (five or more different 
drugs), and number of visits to Primary Care.
Statistical analysis. Descriptive statistics were used to summarize overall information. Participant’s char-
acteristics and disease prevalence were measured at baseline and final year.
For the grouping of participants, it was assumed that patient population was initially distributed into a fuzzy 
set of clusters, corresponding to the different multimorbidity  patterns22. In order to model the temporal evolu-
tion of both individuals and clusters, the sequential individual observations were assumed to follow a dynamic 
random process represented by an HMM so that each cluster was associated with a hidden state or multimor-
bidity pattern.
For the development of the HMM, all features from all individuals at each point of the follow-up were con-
sidered. The HMM was conducted in two stages. In the first stage, the set of features that represent each patient’s 
EHR for each year was selected. To prevent including statistical noise and spurious findings in the model, dis-
eases with a prevalence < 2% at baseline were excluded (Supplementary 1). The dataset was pre-processed by 
applying a mixture of Principal Component Analysis (PCA) to the continuous original features and a Multiple 
Correspondence Analysis (MCA) to the categorical features in order to reduce the number of features on the 
new dataset. Afterwards, a fuzzy segmentation procedure (Fuzzy C-means algorithm or FCM) was applied on 
the new dataset to identify an initial set of clusters, which was used to initialize some of the HMM parameters 
in the next stage. Finally, two more clusters were added with the objective to account for drop-out and death.
In the second stage, the set of HMM parameters, composed of the initial cluster probabilities, the inter cluster 
transition probabilities and the emission distributions provided by FCM, was fitted into the observation data by 
applying the Baum-Welch (BW) algorithm. In this process, data originating from each individual formed a short 
temporal sequence of five available vectors with all their observed features, one vector per year. It was assumed 
that the different sequences were statistically independent of each other, since each sequence corresponds to a 
different  individual23.
Once the model parameters were learned, the longitudinal trajectories followed by the individuals could be 
inferred. In this process, given each observed sequence, the best cluster trajectory is computed by maximizing 
the probability of the observed sequence conditioned to the computed model parameters (Viterbi Algorithm). 
To validate the model, a comparison between BW and Viterbi transition probabilities was conducted, indicating 
a good agreement between theoretical and observed values.
To optimize the performance of the selected mathematical model, the iterative process involved in the appli-
cation of the BW algorithm was initialized using different initial values of the parameters to be learned. The best 
model selected was the model that delivers the highest probability of the available data conditioned to the final 
estimated model parameters. This procedure is equivalent to applying the Bayes Information Criterion to choose 
the best obtained set of HMM parameters. Supplementary 2 includes further methodological information on 
the machine-learning techniques applied to the dataset.
Multimorbidity patterns. The final clusters were defined as multimorbidity patterns. To evaluate the consist-
ency and utility of the final clusters, we used clinical criteria from clusters previously described in the literature, 
together with the consensus opinion of the research team physicians (3 family doctors and 1 epidemiologist). 
To describe the multimorbidity patterns, percentages of diseases (O) in each cluster were calculated. Observed/
expected ratios (O/E-ratios) were obtained by dividing disease prevalence in the cluster by disease prevalence 
in the overall population. Exclusivity (E), defined as the proportion of patients with the disease included in the 
cluster over the total number of patients with the disease, was also calculated. A disease was considered to be part 
of a multimorbidity pattern when the O/E-ratio ≥ 224,25.
In order to account for drop-out and mortality, two more clusters were added. In doing so, data from people 
who transferred and died ceased to contribute to the dynamic characterization of the patterns after the occur-
rence of these events.
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The Cox proportional-hazards regression models were fitted to estimate the mortality hazard of multimor-
bidity patterns at baseline. Time to follow-up was the time between index date and all-cause death. People 
were followed until censored (lost to follow-up or end of observation). Hazard ratios (HR) and 95% confidence 
intervals (CI) were adjusted for age, sex, and socio-economic status (MEDEA index). Multiple Imputation was 
used to minimize the selection bias arising from the presence of missing values for MEDEA (7%), while Chained 
Equations were used to obtain seven imputed datasets. The final models were fitted with the multiple imputation 
datasets using Rubin’s rules to combine effect estimates and standard errors, thus allowing for the uncertainty 
related to missing data.
The analyses were carried out using R version 3.5.1 (R Foundation for Statistical Computing, Vienna, Austria). 
The significance level was set at α = 0.05.
Ethical considerations. The study followed national and international regulations for research involving 
human subjects: Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects 
and Good Research Practice principles and guidelines. The protocol of the study was approved by the Clinical 
Research Ethics Committee, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi 
Gol i Gurina (IDIAPJGol) (P16/151). All data were anonymized and confidentiality of EHR was guaranteed at all 
times in accordance with national and international law (Ley Orgánica 3/2018, de 5 de diciembre, de Protección 
de Datos Personales y garantía de los derechos digitales and General Data Protection Regulation (EU) 2016/679 
(GDPR)); thus, it was not necessary to ask for informed consent to the participants.
Results
In this study, 916,619 individuals were included at baseline (women: 57.7%; mean age: 75.4; standard deviation, 
SD: 7.4), of which 853,085 (93.1%) met multimorbidity criteria. Follow up was completed by 743,827 participants 
(Fig. 1). Ten multimorbidity patterns were identified at baseline, and two additional clusters, representing death 
and dropouts, were added for the five-year analysis.
At baseline, the cluster with the highest proportion of the sample (42%), named Cluster 1 (C1)-Non-Specific 
Pattern, consisted of non-overrepresented diseases such as prostate disease, hypertension, solid neoplasms and 
dyslipidaemia. The remaining patterns, in descending order of sample size, were named with the most over-
represented diseases, for instance, Cluster 2 (C2)-Eye Impairment and Mental (19.3%) (See Supplementary 3 for 
more details).
Women were predominant in the following patterns: C2-Eye Impairment and Mental (73.7%), C4-Cardio-
Circulatory and Renal (70.8%), C7-Respiratory and Ear (74.8%), C9-Nervous, Musculoskeletal and Minor (92.6%), 
C10-Multisystem (89.9%). The only pattern with clear male predominance was C5-Cardio-Circulatory, Mental, 
Respiratory and Genitourinary (93.3%). The mean age for the oldest pattern was 80.6 years (C4-Cardio-Circulatory 
and Renal), and the youngest pattern had a mean age of 72.8 years (C9-Nervous, Musculoskeletal and Minor). 
In relation to socio-economic status, pattern C4-Cardio-Circulatory, Mental, Respiratory and Genitourinary was 
most prevalent among people living in the most deprived areas (see Supplementary 4 for further details on 
multimorbidity patterns).
The clusters with a higher median number of chronic diseases were C10-Multisystem Pattern (11 diseases); 
C4-Cardio-Circulatory and Renal and C9-Nervous, Musculoskeletal and Minor (9 diseases); and C5-Cardio-Cir-
culatory, Mental, Respiratory and Genitourinary (8 diseases). Considering all clusters, the median of diseases 
ranged from 4 to 11. Three clusters presented the highest number of polymedicated patients, with a median of 8 
prescribed drugs: C4-Cardio-Circulatory and Renal (86.0%); C10-Multisystem Pattern (81.4%); and C5-Cardio-
Circulatory, Mental, Respiratory and Genitourinary (80.7%). The median of visits ranged from 7 to 20. The three 
clusters with more median visits were: (1) C4-Cardio-Circulatory and Renal (20 visits); (2) C10-Multisystem 
Pattern (15 visits); (3) C5-Cardio-Circulatory, Mental, Respiratory and Genitourinary (14 visits). Toward the end 
of the study, C4-Cardio-Circulatory and Renal and C5 Cardio-Circulatory, Mental, Respiratory and Genitourinary 
increased the median number of visits (22.0 and 15.0, respectively). The remaining clusters maintained the same 
number of visits at the beginning and at the end of the study period (Supplementary File 4). On the other hand, 
ten clusters showed an equal median number of drugs (ranging from 3 to 8) at the beginning and end of the 
study (Supplementary File 4). The clusters presenting higher mortality were: C4-Cardio-Circulatory and Renal 
(37.1%); C6-Nervous, Digestive and Circulatory (31.8%); and C5-Cardio-Circulatory, Mental, Respiratory and 
Genitourinary (28.8%). The proportion of deaths ranged from 3.3% (C9-Nervous, Musculoskeletal and Minor) 
to 37.1% (C4-Cardio-Circulatory and Renal) (Table 1).
The evolution during follow up of O/E ratio and prevalence (O) for the ten most prevalent chronic diseases 
shown in Fig. 2 indicates that O/E ratio maintains stable or slightly decreases over time and prevalence increases 
over time for all multimorbidity patterns.
Table 1 shows transition probability between clusters. The transition matrix diagonal shows that a high 
proportion of patients remain in the same cluster over the follow-up period. Permanence in the same pattern is 
highest (92.1%) in the C9-Nervous, Musculoskeletal and Minor pattern, and lowest (59.2%) for patients starting in 
the C4-Cardio-Circulatory and Renal pattern. The patterns with highest mortalities were C5-Cardio-Circulatory, 
Mental, Respiratory and Genitourinary; C6-Nervous, Digestive and Circulatory; and C7-Respiratory and Ear.
Transitions and trajectories are shown in Fig. 3. Figure 3a shows the individual cluster longitudinal sequences 
sorted by initial cluster and the number of patients corresponding to each initial cluster, while Fig. 3b shows 
the cluster longitudinal sequences of individuals that finished in the drop-out or death clusters sorted by final 
cluster. Most trajectories consisted in a single transition between two clusters. The most frequent transitions 
were to the death and drop out clusters (Fig. 3b). The most likely transitions to other clusters corresponded from 
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C1-Non-Specific to C3-Minority Metabolic Autoimmune-Inflammatory (4.2%) and from C1 to C2-Eye Impairment 
and Mental (3.5%) (Table 1).
Figure 4 also shows the transition between baseline and final clusters. The proportion of sample remains 
stable for each baseline pattern, except for the C1-Non-Specific pattern, which shows a decrease from 42 to 28%.
The study of the mortality showed that C4-Cardio-Circulatory and Renal; C5 Cardio-Circulatory, Mental, 
Respiratory and Genitourinary; C6-Nervous, Digestive and Circulatory; and C8-Digestive presented the highest 
hazard of death after adjusting for confounders (adjusted HRs over 1.5) (Table 2).
Table 1.  Transition probabilities for Viterbi decoding from start to end of study. Bold show probabilities 
higher than 2%.
Origin\Dest
C1—Non-
Specific
C2—Eye 
Impairment and 
Mental
C3—Minority 
Metabolic 
Autoimmune-
Inflammatory
C4—Cardio-
Circulatory and 
Renal
C5—Cardio-
Circulatory, Mental, 
Respiratory and 
Genitourinary
C6—Nervous, 
Digestive and 
Circulatory
C7—Respiratory 
and Ear C8—Digestive
C9—Nervous, 
Musculoskeletal 
and Minor
C10—Multisystem 
Pattern Dropout Death
C1—Non-
Specific 66.1% 3.5% 4.2% 1.7% 2.0% 2.6% 1.1% 1.2% 0.5% 0.1% 3.2% 13.7%
C2—Eye 
Impairment 
and Mental
0.3% 79.0% 0.7% 2.0% 0.7% 1.9% 1.0% 0.9% 2.1% 1.5% 2.0% 7.9%
C3—Minor-
ity Metabolic 
Autoim-
mune-
Inflammatory
1.3% 0.1% 76.7% 0.6% 0.3% 1.1% 0.5% 0.7% 0.1% 0.3% 2.1% 16.1%
C4—Cardio-
Circulatory 
and Renal
0.1% 0.0% 0.0% 59.2% 0.0% 0.3% 0.1% 0.2% 0.0% 0.1% 2.9% 37.1%
C5—Cardio-
Circulatory, 
Mental, 
Respiratory 
and Genitou-
rinary
0.2% 0.0% 0.1% 0.0% 67.3% 0.8% 0.0% 0.5% 0.0% 0.0% 2.3% 28.8%
C6—Nerv-
ous, Digestive 
and Circula-
tory
1.5% 0.5% 0.2% 0.1% 0.2% 61.2% 0.2% 0.1% 0.1% 0.1% 4.0% 31.8%
C7—Respira-
tory and Ear 1.7% 1.4% 0.4% 0.5% 0.3% 0.7% 77.9% 0.2% 0.4% 0.9% 2.1% 13.7%
C8—Diges-
tive 2.2% 1.4% 0.5% 0.3% 0.3% 0.5% 0.2% 68.4% 0.1% 0.4% 2.5% 23.3%
C9—Nerv-
ous, Muscu-
loskeletal and 
Minor
0.3% 0.7% 0.1% 0.4% 0.0% 0.5% 0.3% 0.1% 92.1% 1.0% 1.1% 3.3%
C10—Mul-
tisystem 
Pattern
0.1% 0.4% 0.0% 0.1% 0.0% 0.1% 0.2% 0.0% 0.0% 85.4% 1.9% 11.6%
Dropout 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 0.0%
Death 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0%
Figure 2.  Prevalence and O/E ratio evolution over time in every cluster. (a) Prevalence (O) evolution over time 
in every cluster. (b) O/E ratio evolution over time in every cluster.
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Figure 3.  Cluster longitudinal sequences of individuals. (a) Cluster longitudinal sequences of individuals sorted 
by initial cluster. (b) Cluster longitudinal sequences of individuals sorted by final cluster (finishing in the death 
and dropout clusters).
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Discussion
Key results. Most studies on the trajectories of multimorbidity have included small samples and few diseases 
and have not used methods able to identify change from multimorbidity patterns over a period of  time26–28. In 
this study conducted with data from primary care EHR, we provide longitudinal information on the multimor-
bidity trajectory of individual patients from a large, representative dataset. The results obtained inform about 
Figure 4.  Transition from Baseline (B) to Final (F).
Table 2.  Cox proportional-hazards regression for mortality cluster. HR hazard ratio. a Sex, Age, MEDEA 
(Complete Cases). b Sex, Age, MEDEA (Multiple Imputation).
C1—Non-Specific
Death
Unadjusted Adjusteda Adjustedb
HR 2.5% 97.5% HR 2.5% 97.5% HR 2.5% 97.5%
C2—Eye Impairment and Mental 0.549 0.539 0.559 0.608 0.595 0.622 0.645 0.632 0.657
C3—Minority Metabolic Autoimmune-Inflammatory 1.227 1.202 1.251 1.015 0.992 1.038 1.064 1.043 1.086
C4—Cardio-Circulatory and Renal 3.373 3.322 3.426 1.978 1.942 2.014 2.086 2.053 2.119
C5—Cardio-Circulatory, Mental, Respiratory and Geni-
tourinary 2.404 2.362 2.447 1.656 1.622 1.692 1.757 1.725 1.790
C6—Nervous, Digestive and Circulatory 2.792 2.740 2.845 1.937 1.896 1.979 1.982 1.945 2.020
C7—Respiratory and Ear 1.038 1.011 1.067 1.031 0.999 1.064 1.102 1.072 1.132
C8—Digestive 1.836 1.794 1.879 1.841 1.791 1.891 1.969 1.924 2.016
C9—Nervous, Musculoskeletal and Minor 0.229 0.216 0.243 0.301 0.280 0.324 0.356 0.335 0.377
C10—Multisystem Pattern 0.890 0.850 0.932 0.684 0.646 0.724 0.812 0.775 0.851
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the direction and magnitude of multimorbidity patterns, on the evolution of diseases in each pattern and on 
temporal trends. Initially, we obtained the following ten multimorbidity patterns: Non-Specific; Eye Impairment 
and Mental Minority Metabolic Autoimmune-Inflammatory; Cardio-Circulatory and Renal; Cardio-Circulatory, 
Mental, Respiratory and Genitourinary; Nervous, Digestive and Circulatory; Respiratory and Ear; Digestive; Nerv-
ous, Musculoskeletal and minor; and finally, the Multisystem Pattern.
A three-stage process was conducted: firstly, we identified the diseases more frequently associated to a mul-
timorbidity pattern using O/E ratio and exclusivity; secondly, we determined the multimorbidity trajectory of a 
patient; thirdly, we observed that most people remained in the same multimorbidity pattern over time and that 
multimorbidity increases with age and with number of diseases, specifically hypertension, dyslipidaemia, obesity 
and diabetes, included in most multimorbidity patterns.
Interpretation of multimorbidity patterns and trajectories. The use of the O/E ratio and exclusivity 
presents a complementary approach to understanding the role of each disease in each multimorbidity pattern. 
The O/E ratio provides information on the most overrepresented disease in each cluster. Exclusivity indicates 
the proportion of patients with the disease in a specific cluster over the total number of patients with the disease. 
The overrepresented diseases are the nuclear diseases in each pattern and represent the diseases that characterize 
people in this cluster. With the use of O/E ratios, the analysis is less influenced by diseases such as hypertension 
and dyslipidaemia, which are highly prevalent in the whole population. Regarding the 10 most prevalent chronic 
diseases, their O/E ratio was stable or slightly decreased over time as shown in Fig. 2. The overrepresented dis-
eases are the nuclear diseases in each  pattern22 and represent the diseases that characterize people in this cluster 
regardless of the most prevalent diseases. If the exclusivity value is considered, the percentage of people with a 
certain disease in a specific cluster can be identified. Consequently, the use of O/E ratio and exclusivity indicate 
which conditions are most likely to co-exist. Therefore, if we look at diabetes as a prevalent disease, we can 
observe in the C2-Eye Impairment and Mental diseases pattern that some diseases such as Glaucoma, Other Eye 
Diseases and Neurotic, Stress-Related and Somatoform Diseases are nuclear diseases. These diseases correspond 
to 39.92% of people in this pattern, which is the most frequent pattern for diabetic persons (exclusivity 30.67%). 
Moreover, this aspect is maintained over the study period, demonstrating that this method describes both the 
evolution of the pattern characteristics over time and the potential risk/progression of certain  diseases29,30. Then, 
we could identify diabetic people who belongs to a specific pattern, C2, and observed the evolution over time, 
for example.
Up to 41.97% of the study population is included in the C1-Non-Specific cluster, whereas only 1.63% of the 
study population is ascribed to the C10-Multisystem pattern. In reality, these two patterns are two sides of the 
same coin: C1 for the elderly with no severe complications of their multimorbidity (the majority of diseases 
are cardiovascular risk factors), and C10 for the elderly who are already suffering from serious complications. 
Importantly, the C1-Non-Specific cluster is the pattern with the youngest and least multimorbid patients. Other 
studies agree that the younger elderly are less frequently diagnosed with multiple  diseases31. Interestingly, this 
same C1-Non-Specific cluster presented the highest percentage of transition, particularly to C3-Minority Metabolic 
Autoimmune-Inflammatory and C2-Eye Impairment and Mental. The transition to the C2-Eye Impairment and 
Mental and C3-Minority Metabolic Autoimmune-Inflammatory cluster is supported by the increasing incidence 
of autoimmune diseases with  ageing32–34.
The patterns that resulted in a higher burden of care, i.e., those with the greater number of polymedicated 
people (median prescription of 8 drugs) and the major number of visits (14 to 20 visits per year), were C4-Car-
dio-Circulatory and Renal, C10-Multisystem Pattern, and C5-Cardio-Circulatory, Mental, Respiratory and Geni-
tourinary. Importantly, C4- Cardio-Circulatory and Renal and C5- Cardio-Circulatory, Mental, Respiratory and 
Genitourinary are among the three patterns with the highest mortality. The financial expense and high care 
burden of these three patterns pose a challenge to health services.
The transition of the persons included in Cluster 1 to C2-Eye Impairment and Mental Diseases can be 
explained through hypertension, which can present long term complications such as hypertension retinopathy 
and glaucoma. The transition from C1 to the C3-Minority Metabolic Autoimmune-Inflammatory cluster should 
be interpreted under the immunosenescence process, a remodelling of the innate and adaptive system associ-
ated with  ageing31–33,35.
No relevant transitions, in terms of probability values, are observed in patients from other clusters. The 
probability of remaining in the same pattern during a 5-year period is over 59% in people over 65 years of age. 
This means that the initial information will determine preventive and management planning for these patients.
Interpretation of mortality. Patterns C4-Cardio-Circulatory and Renal; C5-Cardio-Circulatory, Men-
tal, Respiratory and Genitourinary; C6-Nervous, Digestive and Circulator; and C7-Respiratory and Ear, which 
included cardiovascular, neuropsychiatric, digestive and respiratory diseases were independently associated 
with a higher mortality risk. These findings are consistent with vital statistics reported for Spain, where digestive 
and respiratory are the third and cardiovascular diseases are the first cause of death,  respectively36. These results 
also agree with studies of large databases that followed patients over a 20-year  period37.The highest mortality 
found in pattern C5-Cardio-Circulatory, Mental, Respiratory and Genitourinary might be attributable to a higher 
prevalence of cardiovascular disease in patients with mental health disorders and  dementia36, sometimes caused 
by adverse effects of their pharmacological treatment. It has also been hypothesised that the prevalence of mental 
disorders is higher in patients with cardio-circulatory  diseases38.
Comparison with the literature. Comparison with other studies is difficult, since most studies on multi-
morbidity patterns use cross-sectional instead of longitudinal  data1,39. Analogy of the results of multimorbidity 
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patterns with other studies can be intricate by the methods, data sources and structures, populations and dis-
eases analyzed. Nevertheless, similarities with other authors can be found. The non-specified pattern is the one 
most replicated in the literature, for example, Prados-Torres et al. who employed an exploratory factor  analysis40 
and our group with k-means12 and fuzzy c-means cluster  analysis41. In these last articles it can be verified that 
there is a non-negligible coincidence between the multimorbidity patterns. For example with k-means, we iden-
tified six multimorbidity patterns: Musculoskeletal, Endocrine-Metabolic, Digestive/Digestive-Respiratory, 
Neuropsychiatric, Cardiovascular, and Non-Specific  patterns12.
In the absence of a universal consensus list for the definition of multimorbidity, we used the list created by 
the SNAC-K study, which establishes 60 chronic diseases as an operational measure of multimorbidity. The 
identification of these key relevant diseases has been elaborated by an international and multidisciplinary team 
(geriatricians, general practitioners and epidemiologists), with the purpose of monitoring multimorbidity and 
to allow comparison of multimorbidity among  countries20. In our study, the high number of diseases included 
in the analysis has resulted in a higher percentage of multimorbidity when compared with other observational 
studies which only included 4 to 40  diseases39.
Strengths and limitations. This study is based on a large, high-quality database containing primary care 
records representative of the population with multimorbidity in  Catalonia19. In addition, we used a validated, 
clinically driven methodology to measure chronic diseases, which allows a standardized evaluation of chronic 
diseases in the European  Union20. On the other hand, the EHR used often have incomplete data, since they are 
mainly designed to support clinical  practice42.
Different initializations can be considered in the HMM and there is no guarantee of reaching a global opti-
mum solution, since HMM obtains a local optimum instead. To minimize this effect and to eventually use the 
model with the greatest likelihood, we performed 100 Baum-Welch realizations with different initializations. 
In addition, the HMM is most effective for long periods of time. To address this limitation and increase the 
reliability of the model, the data from all patients was used for every time  interval15. Furthermore, the model’s 
suitability to the dataset has been validated by clinical criteria and analytical verification of the likelihood of the 
model, as explained in the Supplementary 2.
Implications for practice, policy and research. The longitudinal multimorbidity patterns obtained 
with HMM methods provide a comprehensive approach to the evolution of multimorbidity over a patient’s life-
time. Our data can predict the pattern in which an elderly person will be in the next 5 years. Importantly, many 
diseases identified have shared risk factors and consequently preventative interventions in these chronic diseases 
could alter many trajectories and even shift causes of mortality.
We should underline that 42% of the population ≥ 65 years were included in the C1-Non-Specific pattern, 
which in reality encompasses the most prevalent diseases in the elderly. Moreover, since patients in this pattern 
typically transition to other multimorbidity patterns associated with higher mortality, they should be specifically 
targeted for preventive interventions.
We can characterize individuals according to the diseases overrepresented in a specific multimorbidity pattern 
and assume that they have common etiological, genetic and social determinants. The challenge now is to divert 
healthcare policy from individual diseases to a personalized multimorbidity pattern.
Characterization of multimorbidity patterns using HMM can be expanded, for instance aggregating infor-
mation from other health determinants such as fragility. Adding new factors will allow the creation of risk 
algorithms that can be integrated into the EHR to predict future diseases for each individual, opening the door 
to patient-tailored prevention and management.
Further studies need to elucidate the mechanisms underlying the various multimorbidity patterns. This is 
one of the first articles analysing the longitudinal evolution of multimorbidity patterns. These same methods 
should be applied to younger populations for a longer follow-up period to better characterise the patterns and 
determinants of multimorbidity.
conclusions
Four main aspects differentiate and characterise the ten multimorbidity patterns observed: (1) the proportion 
of women was higher in C2-Eye Impairment and Mental; C4-Cardio-circulatory and Renal; C7-Respiratory and 
Ear; and C9-Nervous, Musculoskeletal, and Minor, whereas men predominated in C5-Cardio-circulatory, Mental, 
Respiratory and Genitourinary; (2) the highest mortality rates were observed for C4-Cardio-Circulatory and Renal; 
C6-Nervous, Digestive and Circulatory and C5-Cardio-Circulatory, Mental, Respiratory and Genitourinary; (3) 
trajectories were generally stable, although changes were common in certain patterns of multimorbidity; (4) 
most trajectories consisted of a single transition during 5 years of follow up.
This study sheds light on the changing prevalence of multimorbidity patterns over time and on mortality 
associated with specific patterns. These data are essential for the provision of adequate healthcare for patients 
with multiple chronic conditions. Future studies on the trajectory of multimorbidity patterns should follow up 
a younger population for a longer period of time.
Data availability
The datasets are not available, as researchers have signed an agreement with the Information System for the 
Development of Research in Primary Care (SIDIAP) concerning confidentiality and security of the dataset, 
which forbids providing data to third parties. This organization is subject to periodic audits.
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